Primary Immunodeficiency in Kuwait

NCT03618147 | Completed Results

• 1 other identifier: IIR - K W T - 0 0 2 0 7 1
• Study Type: observational
• Target: 314
• Locations: 1 country
• Sites: 1

Brief Summary

• Background/Rationale: Epidemiological data about Primary Immunodeficiency Disorders (PIDD) in Kuwait is needed to better understand peculiarities and to compare them with other regions and ethnicity.
• Study hypothesis: PIDD is relatively common in Kuwait compared to populations from different geographic areas. The distribution of PIDD in Kuwait is different from other geographic areas with more severe forms being more frequent.
• Brief inclusion and exclusion criteria of study participants: PIDD patients presented at different clinics/hospital in Kuwait. Patients with secondary immunodeficiencies (drug induced, virus induced, and immunodeficiency associated with metabolic disorders... ect), will be excluded
• Estimated sample size of the study: All patients who were registered in KNPIDR since 2004 will be included in the study along with the new patients who will be recruited during the study period.
• Primary objectives:
• Determine the prevalence and frequency of different PIDD in Kuwait
• Identify clinical presentation patterns for PIDD in Kuwait
• Identify natural history of PIDD in Kuwait
• Help to asses epidemiology of PIDD in Kuwait
• Determine particularities about PIDD affecting the population in Kuwait
• Determine the health impact of PIDD in Kuwait
• Development of strategies to improve the care and the quality of life of patients with PIDD

Conditions

Primary Immune Deficiency Disorder

Outcome Measures

Primary Outcomes (2)

• Number of Participants With Different Epidemiological Features

  15 years

• Number of Overall and New Cases of PID Per 100,000 Kuwaitis

  15 years

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

PIDD patients in Kuwait

You may qualify if:

• PIDD patients presented at different clinics/hospital in Kuwait

Sponsors & Collaborators

• Kuwait Society for Allergy and Clinical Immunology: lead

Study Sites (1)

Pediatric Deprtmemt, Alsabah hospital

Kuwait City, Kuwait

Location

MeSH Terms

Conditions

Primary Immunodeficiency Diseases

Condition Hierarchy (Ancestors)

Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immunologic Deficiency Syndromes; Immune System Diseases

Results Point of Contact

• Title: Kuwait Society of Allergy & Clinical Immunology
• Organization: Kuwait Society of Allergy & Clinical Immunology

walherz@hsc.edu.kw

0096524636478

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Target Duration: 5 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor of Pediatrics

Study Record Dates

• First Submitted: July 30, 2018
• First Posted: August 7, 2018
• Study Start: July 16, 2018
• Primary Completion: May 1, 2019
• Study Completion: May 1, 2019
• Last Updated: September 9, 2019
• Results First Posted: September 4, 2019

Record last verified: 2019-09

Data Sharing

• IPD Sharing: Will not share

Locations

KU (1)